CLINICAL_TRIALS
trial_result
· 2016-10-05
Clinical Trial Update: Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature [Phase 3]
Summary
Phase 3 trial evaluating the efficacy and safety of recombinant human growth hormone on height velocity in children with idiopathic short stature; results have …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Growth Disorder, Idiopathic Short Stature | Phase 3 | Status: COMPLETED | Results posted: 2016-10-05